Gallagher Cam's Form 4 filing
Zentalis Pharmaceuticals, Inc. (ZNTL) · filed Jan 5, 2023
- Accession no.
- 0001725160-23-000002
- Filed
- Jan 5, 2023
- Trade date
- Jan 5, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $210.2K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gallagher CamCIK 0001557832 | Director, Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Common Stock | SSaleDisposed | −9,700 | $21.01 | −$203,797 | 362,311 | Direct | |
| Jan 5, 2023 | Common Stock | SSaleDisposed | −300 | $21.46 | −$6,438 | 362,011 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.